Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Argus Health
Accenture
Covington
Boehringer Ingelheim
McKesson
Teva
Queensland Health
US Army

Generated: June 20, 2018

DrugPatentWatch Database Preview

OPTIMINE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Optimine, and what generic alternatives are available?

Optimine is a drug marketed by Schering and is included in one NDA.

The generic ingredient in OPTIMINE is azatadine maleate. There are two drug master file entries for this compound. Additional details are available on the azatadine maleate profile page.
Drug patent expirations by year for OPTIMINE
Synonyms for OPTIMINE
11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine di[(2Z)-but-2-enedioate]
11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine dimaleate
11H-Benzo(5,6)cyclohepta(1,2-b)pyridine, 5,6-dihydro-11-(1-methyl-4-piperidylidene)-, dimaleate
11H-Benzo(5,6)cyclohepta(1,2-b)pyridine, 5,6-dihydro-11-(1-methyl-4-piperidylidene)-,dimaleate
3964-81-6 (Parent)
3978-86-7
5H-Benzo(5,6)cyclohepta(1,2-b)pyridine, 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-, (Z)-2-butenedioate (1:2)
5H-Benzo[5,6]cyclohepta[1,2-b]pyridine, 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-, (2Z)-2-butenedioate (1:2)
6,11-Dihydro-11-(1-methyl-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine maleate (1:2)
6,11-Dihydro-11-(1-methyl-4-piperidylidene)5H-benzo(5,6)cyclohepta(1,2-b)pyridine dimaleate
978A867
AKOS026749836
AN-1225
AOB5374
AS-16886
AT-15578
Azatadine (dimaleate)
Azatadine dimaleate
Azatadine maleate
Azatadine maleate (USP)
Azatadine maleate [USAN:USP]
Azatadine maleate [USAN]
BIS((2Z)-BUT-2-ENEDIOIC ACID); 2-(1-METHYLPIPERIDIN-4-YLIDENE)-4-AZATRICYCLO[9.4.0.0(3),?]PENTADECA-1(11),3,5,7,12,14-HEXAENE
C20H22N2.2C4H4O4
CCG-221230
CHEBI:2947
CHEMBL3544908
CS-2048
D00662
EINECS 223-615-8
F3Q391WTX7
HY-B0170A
Idulian
LS-33772
MFCD00242593
MolPort-006-115-832
Optimine (TN)
PL010234
SC-94598
Sch 10649
SCH-10649
SCHEMBL450675
SR-01000943894
SR-01000943894-1
UNII-F3Q391WTX7
V1798
Zadine

US Patents and Regulatory Information for OPTIMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering OPTIMINE azatadine maleate TABLET;ORAL 017601-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for OPTIMINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering OPTIMINE azatadine maleate TABLET;ORAL 017601-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Schering OPTIMINE azatadine maleate TABLET;ORAL 017601-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Colorcon
Chinese Patent Office
Daiichi Sankyo
Dow
Boehringer Ingelheim
Cerilliant
Deloitte
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.